Business
CSL (ASX:CSL) share price falls amid ongoing AstraZeneca uncertainty
CSL Limited (ASX: CSL) shares are edging lower today as ongoing uncertainty over the side effects of the AstraZeneca COVID-19 vaccine continues. At the time of writing, the CSL share price is trading 0.11% lower at $265.22.
CSL is involved in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. The company advised late last month it is set to produce more than 1 million doses of the AstraZeneca vaccine per week.
It was commissioned by the government to produce 50 million doses of the AstraZeneca vaccine, before the vaccine was found to create a one-in-200,000 chance of blood clots – termed thrombosis with thrombocytopenia – around the brain and abdomen.
This led to the…
-
General18 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General15 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News19 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General22 hours agoTrump remains in ‘exceptional health’, doctor’s note says after check-up